Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators.

N Engl J Med. 2007 Nov 15;357(20):2001-15. Epub 2007 Nov 4.

3.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001820. Review.

PMID:
17636684
4.

Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.

Stone GW, Ellis SG, Colombo A, Dawkins KD, Grube E, Cutlip DE, Friedman M, Baim DS, Koglin J.

Circulation. 2007 Jun 5;115(22):2842-7. Epub 2007 May 21.

5.
6.

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.

Maree AO, Fitzgerald DJ.

Circulation. 2007 Apr 24;115(16):2196-207. Review. No abstract available.

7.

Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.

Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G.

Circulation. 2007 May 1;115(17):2323-30. Epub 2007 Apr 16.

8.

Role of clopidogrel in managing atherothrombotic cardiovascular disease.

Eshaghian S, Kaul S, Amin S, Shah PK, Diamond GA.

Ann Intern Med. 2007 Mar 20;146(6):434-41. Review.

PMID:
17371888
9.

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Dubé C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D; U.S. Preventive Services Task Force.

Ann Intern Med. 2007 Mar 6;146(5):365-75. Review.

PMID:
17339622
10.

Stent thrombosis in randomized clinical trials of drug-eluting stents.

Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE.

N Engl J Med. 2007 Mar 8;356(10):1020-9. Epub 2007 Feb 12.

11.

A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days.

von Beckerath N, Kastrati A, Wieczorek A, Pogatsa-Murray G, Sibbing D, Graf I, Schömig A.

Eur Heart J. 2007 Aug;28(15):1814-9. Epub 2007 Feb 1.

PMID:
17272357
12.

Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.

Angiolillo DJ, Shoemaker SB, Desai B, Yuan H, Charlton RK, Bernardo E, Zenni MM, Guzman LA, Bass TA, Costa MA.

Circulation. 2007 Feb 13;115(6):708-16. Epub 2007 Jan 29.

13.

Platelet P2 receptors: old and new targets for antithrombotic drugs.

Cattaneo M.

Expert Rev Cardiovasc Ther. 2007 Jan;5(1):45-55. Review.

PMID:
17187456
14.

Drug insight: aspirin resistance--fact or fashion?

Patrono C, Rocca B.

Nat Clin Pract Cardiovasc Med. 2007 Jan;4(1):42-50. Review.

PMID:
17180149
15.

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.

Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM.

JAMA. 2007 Jan 10;297(2):159-68. Epub 2006 Dec 5.

PMID:
17148711
16.

G-protein dependent platelet signaling--perspectives for therapy.

Shankar H, Kahner B, Kunapuli SP.

Curr Drug Targets. 2006 Oct;7(10):1253-63. Review.

PMID:
17073586
17.

Protease-activated receptors in cardiovascular diseases.

Leger AJ, Covic L, Kuliopulos A.

Circulation. 2006 Sep 5;114(10):1070-7. Review.

18.

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.

ESPRIT Study Group, Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A.

Lancet. 2006 May 20;367(9523):1665-73. Erratum in: Lancet. 2007 Jan 27;369(9558):274.

PMID:
16714187
19.

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ; CHARISMA Investigators.

N Engl J Med. 2006 Apr 20;354(16):1706-17. Epub 2006 Mar 12.

20.

Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial.

Greenbaum AB, Grines CL, Bittl JA, Becker RC, Kereiakes DJ, Gilchrist IC, Clegg J, Stankowski JE, Grogan DR, Harrington RA, Emanuelsson H, Weaver WD.

Am Heart J. 2006 Mar;151(3):689.e1-689.e10.

PMID:
16504633

Supplemental Content

Support Center